Guideline Swine Flu

What is swine influenza?
Swine Influenza (swine flu) is a respiratory disease of pigs caused by type A influenza virus that regularly causes outbreaks of influenza in pigs. Swine flu viruses cause high levels of illness and low death rates in pigs...read more

Contact Us

Head Office
54-55, Shree Siddhi Vinayak Industrial Area.
Udaipur Kanla, Tikawada (RAJASTHAN)

E-mail: info@medilexicon.in
Web: www.medilexicon.in

”mediLexicon’s impressive of range products and partnered services continue to build a robust pipeline of biosimilar and discovery-led biologicals programs in oncology, nephrology, diabetes and autoimmune diseases” With its record of impeccable quality, mediLexiconis a trusted name in India. mediLexicon’sextensive range of harmaceutical and personal care products have brought health and happiness to millions of people the world over – combining technology and quality with affordability.

Over the years, we have systematically leveraged our technology platforms from enzymes to small molecules to recombinant proteins and antibodies. Through partnerships and alliances, mediLexicon has strategically moved up the value chain from supplying pharmaceutical bulk actives to developing proprietary molecules and our own branded formulations.

In the areas of custom and clinical research services, collaborative partnerships with complementary biotechnology and pharmaceutical companies are yielding rich results. We believe these partnerships will positively impact any and all phases of our discovery portfolio.

Differentiation and a high degree of innovation distinguish all our products and services. Combined with India’s value advantage, they enable us to develop and deliver novel and affordable therapeutics for global unmet medical needs.

mediLexicon now provides a range of innovative Flavours, which bring a unique taste sensation to foods and beverages, and fragrances that deliver the right locative signal.

mediLexicon Flavors are used widely across the food and beverages and pharmaceutical industry from fruit juices and medicinal liquids to baked goods and oral hygiene products.

mediLexicon Fragrances have a variety of applications ranging from personal care products to laundry detergents and room fresheners.

Biopharmaceuticals

mediLexicon is among few companies in the world with a diverse scientific skill base and advanced manufacturing capabilities for the development and commercialization of biopharmaceuticals. We offer a range of products from fermentation derived small molecules to recombinant proteins and antibodies. In the specialized and price-sensitive field of custom manufacturing, we provide high quality, cost-competitive services to domestic and international pharmaceutical companies. Moving up the value chain, we have built a robust branded formulations business that is rapidly expanding our global market presence.

Go to Top

Contract Manufacturing

Small-to-medium sized pharmaceutical and biotech companies are positioned to bring 50 percent of new drug molecules to market in the next decade. With escalating R&D costs and the long path to new medicine, these companies are forced to view outsourcing or contract services as an important part of their manufacturing strategy.

mediLexicon leverages its India cost-base together with its extensive expertise and technology platforms to offer competitive, high quality, custom manufacturing services to a global clientele. Our full set of manufacturing capabilities, include mammalian cell culture fermentation, microbial cell culture fermentation, synthetic chemistry, formulation development for solid dosage (tablets and capsules) for immediate and modified release, injectables (vials, cartridges, lyophilized and pre filled syringes) and a fill finish facility. Our facilities are internationally benchmarked making us partners of choice for companies seeking innovative solutions for their medication delivery needs.

Go to Top

Research Services

High levels of innovation and increased productivity are imperatives of the global healthcare industry. To meet this twin demand, our custom research organization and our clinical research company work in partnership with complementary biotechnology and pharmaceutical companies. We believe these partnerships will positively impact all phases of our discovery portfolio. We are also confident that our well-structured alliances will mitigate the risk of discovery and encourage a stimulating environment of continuous knowledge creation.

Go to Top